U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-----------------------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) February 28, 2007
-----------------
GREATBATCH, INC.
----------------
(Exact name of registrant as specified in its charter)
Delaware 1-16137 16-1531026
--------------------------------------------------------------------------------
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
9645 Wehrle Drive, Clarence, New York 14031
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (716) 759-5600
--------------
Not Applicable
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425).
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240 14a-12).
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b)).
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c)).
Item 1.01. Entry into a Material Definitive Agreement
------------------------------------------
On February 28, 2007, Greatbatch, Inc. (the "Company") issued a joint press
release with St. Jude Medical, Inc. announcing that both parties have
entered into an amended supplier partnering agreement. This amendment
becomes effective March 1, 2007, extends the current agreement through 2013
and establishes Greatbatch as the exclusive supplier of battery technology
and the critical supplier of filtered feedthrough technology to St. Jude
Medical. Additionally, the amendment provides for year over year price
reductions on both technologies through collaboration on manufacturing and
supply chain efficiencies. The parties have also agreed to jointly develop
new technologies, including the introduction of a new low cost power
solution to support future market requirements with an implementation date
of no later than 2009.
The Company intends to file a copy of the agreement with its Quarterly
Report on Form 10-Q for the fiscal quarter ended March 30, 2007.
A copy of the release is furnished with this report as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits
99.1 Press Release dated February 28, 2007.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Dated: February 28, 2007 GREATBATCH, INC.
By: /s/ Thomas J. Mazza
-------------------
Thomas J. Mazza
Senior Vice President and
Chief Financial Officer
EXHIBIT
NUMBER DESCRIPTION
------ -----------
99.1 Press Release of Greatbatch, Inc. dated February 28, 2007.